✨ Your Portfolio is fetched and updated from zerodha.
Nano Pharmaceuticals
Market Cap
₹352 Cr.
P/E
46.86

Key Ratios

Market cap
Market cap
352 Cr
PE
PE
46.86
Prom Holding
Prom Holding
58.16 %
ROE (%)
ROE (%)
7.74
ROCE (%)
ROCE (%)
10.34
Div Yield (%)
Div Yield (%)
-
Sales
Sales
141 Cr
OPM (%)
OPM (%)
12.67 %
Debt to Equity
Debt to Equity
0.37

About

Lyka Labs Limited (Lyka) is an India-based healthcare company. The Company is manufacture of l… Read more
Low
97
52W Range
High
177
  • Lyka Labs
  • Zim Laboratories
  • Medico Remedies

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statement

New
Edit rows

Forensics

8 Yes

Positive for this company

2 Neutral

Neutral for this company

7 No

Negative for this company

0 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Peer Comparison

FAQs on Lyka Labs Ltd. Business

Lyka Labs Limited, based in India, specializes in manufacturing lyophilized products, primarily focusing on pharmaceutical products and services. They offer a variety of lyophilized products for both domestic and international markets.

Lyka Labs major competitors are Zim Laboratories, Trident Lifeline, Medico Remedies, Vaidya Sane Ayur Lab, Gennex Lab, Balaxi Pharma., Ambalal Sarabhai Ent.
Market Cap of Lyka Labs is ₹351 Crs.
While the median market cap of its peers are ₹294 Crs.

Lyka Labs seems to be less financially stable compared to its competitors.
Altman Z score of Lyka Labs is 4.51 and is ranked 6 out of its 8 competitors.

Company Filing

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary

Discussions & Analysis

Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material